M. A. Nahit Sendur Et Al. , "Can bevacizumab be a new treatment approach in metastatic melanoma?," Journal of B.U.ON. , vol.17, no.3, pp.601-602, 2012
Nahit Sendur, M. A. Et Al. 2012. Can bevacizumab be a new treatment approach in metastatic melanoma?. Journal of B.U.ON. , vol.17, no.3 , 601-602.
Nahit Sendur, M. A., Ozdemir, N., AKSOY, S., Akinci, M., & ZENGİN, N., (2012). Can bevacizumab be a new treatment approach in metastatic melanoma?. Journal of B.U.ON. , vol.17, no.3, 601-602.
Nahit Sendur, Mehmet Et Al. "Can bevacizumab be a new treatment approach in metastatic melanoma?," Journal of B.U.ON. , vol.17, no.3, 601-602, 2012
Nahit Sendur, Mehmet A. Et Al. "Can bevacizumab be a new treatment approach in metastatic melanoma?." Journal of B.U.ON. , vol.17, no.3, pp.601-602, 2012
Nahit Sendur, M. A. Et Al. (2012) . "Can bevacizumab be a new treatment approach in metastatic melanoma?." Journal of B.U.ON. , vol.17, no.3, pp.601-602.
@article{article, author={Mehmet Ali Nahit Sendur Et Al. }, title={Can bevacizumab be a new treatment approach in metastatic melanoma?}, journal={Journal of B.U.ON.}, year=2012, pages={601-602} }